Lymphoma in Dogs: Signs, Diagnosis, and Treatment

Understanding Lymphoma in Dogs

Lymphoma is one of the most commonly diagnosed cancers in dogs, affecting lymphoid tissues throughout the body. This malignant condition arises from the uncontrolled proliferation of lymphocytes, which are vital components of the immune system. Understanding this disease is crucial for dog owners, as early detection and prompt treatment can significantly improve a dog’s quality of life and survival time. Lymphoma can develop in dogs of any age, but it is more frequently observed in middle-aged and older dogs.

The disease manifests in several forms, with multicentric lymphoma being the most common presentation in dogs. This systemic form affects multiple lymph nodes throughout the body, making it relatively easy to detect during physical examination. Other forms include gastrointestinal lymphoma, cutaneous lymphoma, and mediastinal lymphoma, each presenting unique challenges and treatment considerations.

What Is Lymphoma?

Lymphoma in dogs is a cancer that develops from malignant lymphocytes, which are white blood cells that normally help fight infection and disease. When these cells become cancerous, they multiply uncontrollably and accumulate in lymphoid tissues, including lymph nodes, bone marrow, thymus, spleen, and other organs. This abnormal proliferation disrupts normal immune function and can lead to serious complications if left untreated.

The disease is classified based on several factors, including the type of lymphocyte involved (B-cell or T-cell), the location of the cancer, and the grade of aggressiveness. Advanced genetic studies have revealed that lymphoma can be molecularly distinguished into discrete groups that correlate with biological aggressiveness, helping veterinarians predict disease progression and treatment response.

Clinical Signs of Lymphoma

Recognizing the early warning signs of lymphoma is essential for prompt diagnosis and treatment. The clinical presentation varies depending on the type and location of the lymphoma, but dog owners should be vigilant for several key symptoms.

Common Symptoms

The most common sign of multicentric lymphoma is swelling of the lymph nodes, particularly those located in easily observable areas. These include:

• Lymph nodes in the neck (submandibular lymph nodes)
• Lymph nodes in the chest cavity
• Lymph nodes in the armpits
• Lymph nodes in the groin
• Lymph nodes behind the knees (popliteal lymph nodes)

Many dogs with multicentric lymphoma show no signs of illness at the time of diagnosis, with lymph node swelling being the primary indicator. However, as the disease progresses, additional symptoms develop:

• Weight loss
• Lethargy and decreased energy
• Loss of appetite or decreased appetite
• Swelling of the face or limbs (edema)
• Breathing difficulties or coughing (if chest lymph nodes are enlarged)
• Increased thirst and urination

Gastrointestinal Lymphoma Symptoms

Dogs with gastrointestinal lymphoma typically experience different clinical signs related to digestive system involvement. These symptoms include vomiting, watery diarrhea (often very dark in color), weight loss, and loss of appetite. This form of lymphoma can be more challenging to diagnose since the affected lymph nodes are internal and not visible during physical examination.

Diagnosis of Canine Lymphoma

Proper diagnosis is critical for developing an effective treatment plan. Veterinarians use several diagnostic methods to confirm lymphoma and determine its type and stage.

Diagnostic Procedures

Lymphoma can be diagnosed through multiple approaches:

• Fine-needle aspiration with cytologic evaluation: This minimally invasive procedure involves collecting cells from the enlarged lymph node using a small needle. The cells are then examined under a microscope to identify malignant lymphocytes.
• Lymph node biopsy with histologic evaluation: A tissue sample is collected from the lymph node and examined microscopically to confirm the diagnosis and determine the type of lymphoma.
• Flow cytometry: This advanced molecular technique analyzes the characteristics of lymphocytes to determine if they are normal or cancerous and identifies whether B-cells or T-cells are involved.
• PCR for antigen receptor rearrangement (PARR) assay: This molecular diagnostic technique helps identify clonal proliferation of lymphocytes, confirming the presence of malignant lymphoma.

Additional imaging studies, such as chest radiographs or abdominal ultrasound, may be recommended to assess the extent of disease and determine the stage of lymphoma.

Treatment Options for Lymphoma in Dogs

Several treatment approaches are available for managing canine lymphoma, with the choice depending on the type and stage of disease, the dog’s overall health status, and the owner’s preferences and financial considerations.

Chemotherapy

Chemotherapy is the most effective and widely recommended treatment for canine lymphoma. Dogs tolerate chemotherapy significantly better than humans, rarely experiencing hair loss or severe illness during treatment. The most common chemotherapy protocol used is CHOP, which combines four different drugs for enhanced effectiveness.

CHOP Protocol Components:

• Cyclophosphamide
• Doxorubicin (hydroxydaunorubicin)
• Vincristine
• Prednisone

Other chemotherapy agents used for lymphoma treatment include lomustine (CCNU), typically used for cutaneous lymphoma, and l-asparaginase, which is often reserved for clinically ill dogs or cases of relapse.

Treatment Administration: Chemotherapy is administered through various procedures, most commonly consisting of injections given weekly. Treatment protocols can be delivered intravenously or orally, depending on the specific drugs used and the individual patient’s needs. Initial response rates to conventional systemic chemotherapy are excellent, with 80-90% of dogs achieving remission (complete absence of symptoms). Remission typically lasts an average of 6-12 months, though some dogs may achieve longer disease-free intervals.

Side Effects: While chemotherapy in dogs is generally well-tolerated, some side effects may occur. The most common include vomiting, diarrhea, and decreased appetite, though these effects are not observed in all dogs. Bone marrow suppression can also occur, potentially leading to decreased white blood cell counts. Most side effects are temporary and usually resolve once chemotherapy treatments are finished or discontinued. Veterinarians can prescribe medications to minimize or control these adverse effects.

Prednisone Treatment

Prednisone is a steroid medication that can be used as an alternative or adjunctive treatment for lymphoma. While prednisone does not treat lymphoma directly, it can temporarily reduce clinical signs and improve the dog’s comfort level. This option is often chosen by owners who prefer not to pursue aggressive chemotherapy due to personal or financial reasons. Prednisone monotherapy typically provides shorter-term benefit compared to combination chemotherapy protocols, extending life expectancy but generally for a more limited duration.

Radiation Therapy

In select cases, radiation therapy may be recommended as an adjunctive treatment alongside chemotherapy. Recent research suggests that half-body radiation therapy in conjunction with chemotherapy might improve long-term control of canine lymphoma. Radiation therapy can be particularly useful for localizing disease or managing specific sites of involvement that may not respond adequately to systemic chemotherapy alone.

Surgical Intervention

In some cases involving localized, low-grade disease affecting specific organs such as the spleen, surgical removal (splenectomy) may be an effective treatment option without requiring adjuvant chemotherapy. Additionally, removal of affected lymph nodes or organs may be recommended in select cases to reduce tumor burden.

Bone Marrow Transplantation

Autologous bone marrow transplantation represents an emerging treatment option for canine lymphoma. In this procedure, malignant lymphoma cells are ablated through intensive chemoradiation strategies, and autologous bone marrow cells are reinfused to rescue the patient’s hematopoietic system. However, this aggressive treatment remains experimental and is only available through very few specialized centers.

Treatment Outcomes and Prognosis

The prognosis for dogs with lymphoma depends on several factors, including the stage and type of cancer at diagnosis, the dog’s overall health status, and the treatment approach selected. Without treatment, dogs typically die or require euthanasia within 4-6 weeks. However, with appropriate treatment, the prognosis improves substantially.

With chemotherapy, most dogs achieve improved quality of life and significantly greater overall survival time. While long-lasting remissions can be achieved and the disease is considered treatable, eventual disease relapse is expected in most dogs. Some dogs may develop disease that progressively becomes refractory to continued treatment. However, additional chemotherapy agents or combination protocols can sometimes be used to manage relapsed disease.

For indolent (low-grade) lymphoma, low-intensity oral chemotherapy protocols using chlorambucil and prednisone often provide prolonged survival times exceeding 2 years.

Palliative Care Considerations

For dogs whose owners cannot pursue aggressive chemotherapy or in cases where the disease is refractory to treatment, palliative care focuses on maintaining quality of life and comfort. Prednisone can provide symptomatic relief and extend the dog’s comfortable life span for a limited period. Pain management, nutritional support, and management of specific complications are important components of palliative care.

Frequently Asked Questions

Q: What is the most common type of lymphoma in dogs?

A: Multicentric lymphoma is the most common form, characterized by swelling of multiple lymph nodes throughout the body. It accounts for the majority of canine lymphoma cases.

Q: How quickly does lymphoma progress in dogs?

A: The progression rate varies depending on the type and grade of lymphoma. Without treatment, most dogs decline within 4-6 weeks. With chemotherapy, remission typically lasts 6-12 months on average.

Q: Can lymphoma in dogs be cured?

A: While cure is possible in some cases of indolent lymphoma, most cases are considered treatable but not curable. The goal of treatment is to achieve remission, improve quality of life, and extend survival time.

Q: Do dogs lose their hair during chemotherapy?

A: Unlike humans, dogs rarely lose their hair during chemotherapy. They also typically do not appear to feel ill during treatment, tolerate chemotherapy much better than humans.

Q: Is chemotherapy painful for dogs?

A: Chemotherapy injections are generally not more painful than routine vaccinations. Dogs tolerate the treatment well, and the side effects that do occur are typically manageable.

Q: What should I do if I notice enlarged lymph nodes on my dog?

A: Schedule an appointment with your veterinarian promptly. While enlarged lymph nodes can have benign causes, they should be evaluated professionally. Early diagnosis significantly improves treatment outcomes.

Q: How much does lymphoma treatment cost?

A: Treatment costs vary depending on the protocol and individual circumstances. Discuss financial concerns with your veterinarian, as there are options available at different price points, including palliative care with prednisone.

Q: How often will my dog need veterinary visits during chemotherapy?

A: Most chemotherapy protocols involve weekly injections, requiring regular veterinary visits. Your veterinarian will establish a schedule based on the specific treatment plan and your dog’s response.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete